Concepts (69)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sarcoidosis | 1 | 2014 | 23 | 0.510 |
Why?
|
Early Diagnosis | 1 | 2014 | 75 | 0.500 |
Why?
|
Multimodal Imaging | 1 | 2014 | 52 | 0.500 |
Why?
|
Cardiomyopathies | 1 | 2014 | 69 | 0.480 |
Why?
|
Coffee | 1 | 2009 | 16 | 0.380 |
Why?
|
Infarction | 1 | 2007 | 15 | 0.330 |
Why?
|
Heart Failure | 2 | 2011 | 654 | 0.310 |
Why?
|
Hospitalization | 2 | 2011 | 1092 | 0.250 |
Why?
|
Muscle, Skeletal | 1 | 2007 | 578 | 0.230 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2007 | 531 | 0.220 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2022 | 367 | 0.160 |
Why?
|
Caenorhabditis elegans | 1 | 2022 | 563 | 0.140 |
Why?
|
Brachial Artery | 1 | 2014 | 28 | 0.130 |
Why?
|
Vasodilation | 1 | 2014 | 26 | 0.130 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2014 | 25 | 0.130 |
Why?
|
Sweden | 2 | 2011 | 34 | 0.120 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 133 | 0.120 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 153 | 0.120 |
Why?
|
Atherosclerosis | 1 | 2014 | 149 | 0.110 |
Why?
|
Incidence | 3 | 2011 | 1121 | 0.110 |
Why?
|
Echocardiography | 1 | 2014 | 310 | 0.110 |
Why?
|
Coffea | 1 | 2011 | 3 | 0.110 |
Why?
|
Drinking Behavior | 1 | 2011 | 9 | 0.110 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 750 | 0.110 |
Why?
|
Follow-Up Studies | 3 | 2014 | 1936 | 0.100 |
Why?
|
Survival Rate | 2 | 2009 | 656 | 0.100 |
Why?
|
Biomarkers | 1 | 2014 | 1002 | 0.090 |
Why?
|
Disease-Free Survival | 1 | 2009 | 177 | 0.090 |
Why?
|
Cause of Death | 1 | 2009 | 172 | 0.090 |
Why?
|
Prognosis | 2 | 2009 | 1250 | 0.090 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2009 | 36 | 0.090 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 131 | 0.090 |
Why?
|
Cardiac Catheterization | 1 | 2009 | 163 | 0.080 |
Why?
|
Inflammation | 1 | 2014 | 978 | 0.080 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2007 | 127 | 0.080 |
Why?
|
Male | 5 | 2014 | 23121 | 0.080 |
Why?
|
Prospective Studies | 2 | 2011 | 2519 | 0.080 |
Why?
|
Registries | 1 | 2009 | 643 | 0.070 |
Why?
|
Aged | 5 | 2014 | 10871 | 0.070 |
Why?
|
Time Factors | 2 | 2009 | 3127 | 0.070 |
Why?
|
Electrocardiography | 1 | 2007 | 358 | 0.070 |
Why?
|
Adult | 2 | 2014 | 13325 | 0.070 |
Why?
|
Humans | 7 | 2014 | 49598 | 0.070 |
Why?
|
Somatotypes | 1 | 2022 | 2 | 0.060 |
Why?
|
Body Size | 1 | 2022 | 23 | 0.060 |
Why?
|
Larva | 1 | 2022 | 126 | 0.060 |
Why?
|
Surveys and Questionnaires | 1 | 2009 | 2284 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 1 | 2007 | 1049 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2007 | 835 | 0.050 |
Why?
|
Middle Aged | 3 | 2014 | 13448 | 0.050 |
Why?
|
Risk Factors | 1 | 2009 | 4246 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 1376 | 0.050 |
Why?
|
Female | 5 | 2014 | 26314 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2014 | 4513 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2014 | 4222 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2014 | 175 | 0.030 |
Why?
|
Ultrasonography | 1 | 2014 | 387 | 0.030 |
Why?
|
Prevalence | 1 | 2014 | 1121 | 0.020 |
Why?
|
Cytokines | 1 | 2014 | 816 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 627 | 0.020 |
Why?
|
Rhode Island | 1 | 2009 | 82 | 0.020 |
Why?
|
Recovery of Function | 1 | 2009 | 192 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2009 | 176 | 0.020 |
Why?
|
Stroke Volume | 1 | 2009 | 241 | 0.020 |
Why?
|
Shock, Cardiogenic | 1 | 2007 | 57 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2009 | 1142 | 0.020 |
Why?
|
Animals | 1 | 2022 | 17697 | 0.020 |
Why?
|
United States | 1 | 2014 | 6227 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2007 | 3887 | 0.010 |
Why?
|